by Abhishaike Mahajan
a podcast about biology and computation <br/><br/><a href="https://www.owlposting.com/s/podcast?utm_medium=podcast">www.owlposting.com</a>
Language
🇺🇲
Publishing Since
7/20/2024
Email Addresses
1 available
Phone Numbers
0 available
February 3, 2025
<p></p><p>This is an interview with <a target="_blank" href="https://www.linkedin.com/in/sohamsankaran/overlay/about-this-profile/">Soham Sankaran</a>, the founder and CEO of <a target="_blank" href="https://popvax.com/">PopVax</a>, an mRNA vaccine development startup.</p><p>Curiously, PopVax is based in India, specifically Hyderabad. This should be a surprise to most people in the field: we never really hear of interesting biotech research being done in a place that isn’t [US, Europe, East Asia].</p><p>Yet, PopVax has been astonishingly successful, <a target="_blank" href="https://chronicles.popvax.com/p/potent-broadly-protective-flu-vaccines">having a (in mouse) influenza vaccine that is 250x better than its competitors,</a> <a target="_blank" href="https://www.businesswire.com/news/home/20241029589496/en/PopVax-Announces-1.15-Million-USD-in-Funding-from-the-Bill-Melinda-Gates-Foundation-for-Thermostable-mRNA-Delivery-Formulation-Development">multiple large research collaborations</a>, and their <a target="_blank" href="https://www.businesswire.com/news/home/20241113245697/en/PopVax-Announces-that-the-U.S.-National-Institute-of-Allergy-and-Infectious-Diseases-will-Conduct-and-Sponsor-the-U.S.-based-Phase-I-Clinical-Trial-of-PopVax%E2%80%99s-Next-Generation-mRNA-LNP-COVID-19-Vaccine-as-part-of-the-U.S.-Government%E2%80%99s-Project-NextGen">first upcoming US based phase 1 clinical trial being fully sponsored and conducted by the NIH</a>.</p><p>It’s an extremely interesting success story from what feels like a very clear underdog. In this 2-hour podcast, we discuss everything from why so little biotech research gets done in India, a breakdown on what you care about in vaccine design (immunogens), how PopVax uses machine learning for precise immunogen design, how raising money for a vaccinology startup is going, and a <strong>lot</strong> more.</p><p>Timestamps and transcripts are below. Just as in my last episode, I’ve included a ‘jargon explanation’ as a quick primer for some of the subjects discussed in the episode.</p><p>Some final bits: the studio rental costs were kindly covered by <a target="_blank" href="https://www.linkedin.com/in/deploy/">Dylan Reid</a>! Huge shout-out to him for making this episode possible. Also shout-out to Samarth Jajoo, Reha Mathur, and David Yang for some very helpful discussion about the Indian biotech scene. And, if you think PopVax is interesting,<a target="_blank" href="https://chronicles.popvax.com/"> here is their Substack</a> which has some articles on their results, <a target="_blank" href="https://jobs.popvax.com/">their job section</a> (they are actively hiring), and can be reached at [email protected].</p><p></p><p>Timestamps</p><p>01:31 Introduction</p><p>02:38 Why is there such little biotech research in India?</p><p>17:43 Advantages of building a company in India</p><p>31:30 Policy prescriptions for India</p><p>35:39 Questions on vaccine design</p><p>50:55 What does PopVax do?</p><p>01:01:58 The role of machine learning in vaccine design</p><p>01:12:07 The (conservative) culture of vaccinology</p><p>01:26:57 Hiring in India</p><p>01:46:52 How fundraising for an Indian vaccine design startup is coming along</p><p>01:57:36 How is PopVax so good at designing vaccines?</p><p>02:02:07 Pet theories on immune mechanisms</p><p>02:09:07 mRNA beyond infectious diseases</p><p>02:12:38 What would you do with $100 million dollars?</p> <br/><br/>Get full access to Owl Posting at <a href="https://www.owlposting.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4">www.owlposting.com/subscribe</a>
December 3, 2024
Corin and Ari Wagen explore the potential of AI to revolutionize molecular simulation, discussing neural network potentials, computational chemistry, and the future of the field.
July 27, 2024
<p>I go through some questions I’ve had about longevity research, with plenty of background info, and give the answers I’ve found. </p><p>Audio version of this essay:</p> <br/><br/>Get full access to Owl Posting at <a href="https://www.owlposting.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4">www.owlposting.com/subscribe</a>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.